(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC27A2 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1346073 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of SLC27A2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO RGD:737177 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC27A2 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1346073 6480464 Estradiol affects the expression of SLC27A2 mRNA CTD PMID:14699072 17beta-estradiol multiple interactions ISO RGD:1346073 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC27A2 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions ISO RGD:737177 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SLC27A2 mRNA CTD PMID:19693291 17beta-estradiol increases expression ISO RGD:1346073 6480464 Estradiol results in increased expression of SLC27A2 mRNA CTD PMID:21185374 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:737177 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:737177 6480464 2 more ... CTD PMID:30294300 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid increases expression EXP 6480464 2 more ... CTD PMID:30920876 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737177 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC27A2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC27A2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737177 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737177 6480464 Tetrachlorodibenzodioxin affects the expression of SLC27A2 mRNA CTD PMID:18343893 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737177 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC27A2 mRNA CTD PMID:15800033 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346073 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC27A2 mRNA CTD PMID:22903824 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1346073 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC27A2 mRNA CTD PMID:21998131 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:737177 6480464 2 more ... CTD PMID:18343893 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene decreases expression ISO RGD:737177 6480464 2, 4-dinitrotoluene results in decreased expression of SLC27A2 mRNA CTD PMID:24893713 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SLC27A2 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:737177 6480464 3 more ... CTD PMID:23994337 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:737177 6480464 3 more ... CTD PMID:19467301 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC27A2 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol affects expression ISO RGD:737177 6480464 bis4-hydroxyphenylsulfone affects the expression of SLC27A2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:737177 6480464 Fenretinide results in increased expression of SLC27A2 mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of SLC27A2 mRNA CTD PMID:19483382 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:1346073 6480464 [6-4-chlorophenylimidazo2 more ... CTD PMID:30611723 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of SLC27A2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC27A2 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:1346073 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC27A2 mRNA CTD PMID:22079614 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC27A2 mRNA CTD PMID:31881176 adefovir pivoxil decreases expression ISO RGD:1346073 6480464 adefovir dipivoxil results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 aflatoxin B1 affects expression ISO RGD:1346073 6480464 Aflatoxin B1 affects the expression of SLC27A2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1346073 6480464 Aflatoxin B1 results in decreased methylation of SLC27A2 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:737177 6480464 Aflatoxin B1 results in decreased expression of SLC27A2 mRNA CTD PMID:19770486 aflatoxin B2 decreases methylation ISO RGD:1346073 6480464 aflatoxin B2 results in decreased methylation of SLC27A2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1346073 6480464 Tretinoin results in decreased expression of SLC27A2 mRNA CTD PMID:23724009 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of SLC27A2 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC27A2 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1346073 6480464 Antirheumatic Agents results in decreased expression of SLC27A2 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1346073 6480464 Arsenic Trioxide results in increased expression of SLC27A2 mRNA CTD PMID:22521957 belinostat multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SLC27A2 mRNA CTD PMID:27188386 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of SLC27A2 mRNA CTD PMID:19483382 benzo[a]pyrene multiple interactions ISO RGD:737177 6480464 Benzoapyrene promotes the reaction [AHR protein binds to SLC27A2 promoter] CTD PMID:19654925 benzo[a]pyrene decreases expression ISO RGD:1346073 6480464 Benzoapyrene results in decreased expression of SLC27A2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1346073 6480464 Benzoapyrene affects the methylation of SLC27A2 intron, Benzoapyrene affects the methylation of SLC27A2 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1346073 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene increases methylation ISO RGD:1346073 6480464 benzoepyrene results in increased methylation of SLC27A2 polyA tail CTD PMID:30157460 benzo[e]pyrene decreases methylation ISO RGD:1346073 6480464 benzoepyrene results in decreased methylation of SLC27A2 intron CTD PMID:30157460 benzylpenicillin multiple interactions ISO RGD:737177 6480464 [Penicillin G co-treated with Erythromycin] results in increased expression of SLC27A2 mRNA CTD PMID:27503388 beta-naphthoflavone increases expression ISO RGD:737177 6480464 beta-Naphthoflavone results in increased expression of SLC27A2 mRNA CTD PMID:23994337 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of SLC27A2 mRNA CTD PMID:16648578 bezafibrate multiple interactions ISO RGD:737177 6480464 Bezafibrate inhibits the reaction [SLC27A2 gene mutant form results in decreased expression of ACADM mRNA], PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of SLC27A2 mRNA] CTD PMID:11929713 , PMID:19124612 bezafibrate increases expression ISO RGD:737177 6480464 Bezafibrate results in increased expression of SLC27A2 mRNA CTD PMID:17118139 , PMID:19124612 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:737177 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A decreases expression ISO RGD:737177 6480464 bisphenol A results in decreased expression of SLC27A2 mRNA CTD PMID:21932408 bisphenol A affects expression ISO RGD:737177 6480464 bisphenol A affects the expression of SLC27A2 mRNA CTD PMID:30951980 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC27A2 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC27A2 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:737177 6480464 [bisphenol A co-treated with sodium arsenite] results in increased expression of SLC27A2 mRNA more ... CTD PMID:28433925 , PMID:30208560 bisphenol A affects methylation ISO RGD:737177 6480464 bisphenol A affects the methylation of SLC27A2 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC27A2 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:737177 6480464 bisphenol F results in increased expression of SLC27A2 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:737177 6480464 1, 3-butadiene results in decreased expression of SLC27A2 mRNA CTD PMID:29038090 cadmium dichloride decreases expression ISO RGD:1346073 6480464 Cadmium Chloride results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 cadmium dichloride multiple interactions ISO RGD:737177 6480464 [Cadmium Chloride co-treated with methylmercuric chloride] results in increased expression of SLC27A2 mRNA CTD PMID:27814245 cadmium dichloride increases expression ISO RGD:737177 6480464 Cadmium Chloride results in increased expression of SLC27A2 mRNA CTD PMID:26352046 calcitriol increases expression ISO RGD:1346073 6480464 Calcitriol results in increased expression of SLC27A2 mRNA CTD PMID:27107558 chloroacetaldehyde decreases expression ISO RGD:1346073 6480464 chloroacetaldehyde results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 chromium(6+) affects expression ISO RGD:737177 6480464 chromium hexavalent ion affects the expression of SLC27A2 mRNA CTD PMID:28472532 chromium(6+) affects expression ISO RGD:1346073 6480464 chromium hexavalent ion affects the expression of SLC27A2 mRNA CTD PMID:30690063 cidofovir anhydrous decreases expression ISO RGD:1346073 6480464 Cidofovir results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:737177 6480464 Ciguatoxins affects the expression of SLC27A2 mRNA CTD PMID:18353800 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of SLC27A2 mRNA CTD PMID:19483382 , PMID:27665778 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of SLC27A2 mRNA CTD PMID:32741898 clofibrate increases expression ISO RGD:737177 6480464 Clofibrate results in increased expression of SLC27A2 mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:737177 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A2 mRNA] CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC27A2 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SLC27A2 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1346073 6480464 cobaltous chloride results in decreased expression of SLC27A2 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1346073 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC27A2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1346073 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC27A2 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1346073 6480464 Copper Sulfate results in decreased expression of SLC27A2 mRNA CTD PMID:19549813 coumarin affects expression EXP 6480464 coumarin affects the expression of SLC27A2 mRNA CTD PMID:16963487 coumestrol increases expression ISO RGD:1346073 6480464 Coumestrol results in increased expression of SLC27A2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1346073 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:737177 6480464 Asbestos, Crocidolite results in increased expression of SLC27A2 mRNA CTD PMID:29279043 CU-O LINKAGE decreases expression ISO RGD:1346073 6480464 cupric oxide results in decreased expression of SLC27A2 mRNA CTD PMID:22077320 cyclosporin A decreases expression ISO RGD:737177 6480464 Cyclosporine results in decreased expression of SLC27A2 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1346073 6480464 Cyclosporine results in decreased expression of SLC27A2 mRNA CTD PMID:20106945 more ... cylindrospermopsin decreases expression ISO RGD:737177 6480464 cylindrospermopsin results in decreased expression of SLC27A2 mRNA CTD PMID:20936652 deoxycholic acid multiple interactions ISO RGD:1346073 6480464 Deoxycholic Acid inhibits the reaction [SLC27A2 protein results in increased uptake of Fatty Acids] CTD PMID:22531947 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of SLC27A2 mRNA CTD PMID:15102944 diarsenic trioxide increases expression ISO RGD:1346073 6480464 Arsenic Trioxide results in increased expression of SLC27A2 mRNA CTD PMID:22521957 dicrotophos decreases expression ISO RGD:1346073 6480464 dicrotophos results in decreased expression of SLC27A2 mRNA CTD PMID:28302478 dioxygen decreases expression ISO RGD:1346073 6480464 Oxygen deficiency results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC27A2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1346073 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of SLC27A2 mRNA CTD PMID:19167446 erythromycin A multiple interactions ISO RGD:737177 6480464 [Penicillin G co-treated with Erythromycin] results in increased expression of SLC27A2 mRNA CTD PMID:27503388 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Dietary Fats] results in increased expression of SLC27A2 mRNA CTD PMID:21051528 ethanol multiple interactions ISO RGD:1346073 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of SLC27A2 mRNA CTD PMID:23378141 farnesol increases expression ISO RGD:1346073 6480464 Farnesol analog results in increased expression of SLC27A2 mRNA CTD PMID:30611723 fenofibrate increases expression ISO RGD:737177 6480464 Fenofibrate results in increased expression of SLC27A2 mRNA CTD PMID:17118139 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SLC27A2 mRNA CTD PMID:27665778 , PMID:32741898 fenofibrate increases expression ISO RGD:1346073 6480464 Fenofibrate results in increased expression of SLC27A2 mRNA CTD PMID:25572481 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC27A2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1346073 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of SLC27A2 mRNA CTD PMID:23378141 folpet decreases expression ISO RGD:737177 6480464 folpet results in decreased expression of SLC27A2 mRNA CTD PMID:31558096 fructose decreases expression ISO RGD:737177 6480464 Fructose results in decreased expression of SLC27A2 protein CTD PMID:28257781 fumonisin B1 decreases expression ISO RGD:737177 6480464 fumonisin B1 results in decreased expression of SLC27A2 mRNA CTD PMID:16221962 furan decreases expression EXP 6480464 furan results in decreased expression of SLC27A2 mRNA CTD PMID:15120968 furan increases methylation EXP 6480464 furan results in increased methylation of SLC27A2 gene CTD PMID:22079235 gemfibrozil affects expression EXP 6480464 Gemfibrozil affects the expression of SLC27A2 mRNA CTD PMID:27665778 genistein increases expression ISO RGD:737177 6480464 Genistein results in increased expression of SLC27A2 mRNA CTD PMID:32186404 GW 4064 multiple interactions ISO RGD:1346073 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of SLC27A2 mRNA CTD PMID:30611723 GW 4064 increases expression ISO RGD:1346073 6480464 GW 4064 results in increased expression of SLC27A2 mRNA CTD PMID:30611723 GW 7647 increases expression ISO RGD:1346073 6480464 GW 7647 results in increased expression of SLC27A2 mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO RGD:1346073 6480464 [GW 7647 co-treated with Oleic Acid] results in increased expression of SLC27A2 mRNA CTD PMID:30611723 hydrogen peroxide affects expression ISO RGD:1346073 6480464 Hydrogen Peroxide affects the expression of SLC27A2 mRNA CTD PMID:23410634 isotretinoin decreases expression ISO RGD:1346073 6480464 Isotretinoin results in decreased expression of SLC27A2 mRNA CTD PMID:20436886 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of SLC27A2 mRNA CTD PMID:19483382 menadione affects expression ISO RGD:1346073 6480464 Vitamin K 3 affects the expression of SLC27A2 mRNA CTD PMID:20044591 , PMID:23410634 mercury dibromide multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SLC27A2 mRNA CTD PMID:27188386 methapyrilene increases methylation ISO RGD:1346073 6480464 Methapyrilene results in increased methylation of SLC27A2 polyA tail CTD PMID:30157460 methapyrilene decreases methylation ISO RGD:1346073 6480464 Methapyrilene results in decreased methylation of SLC27A2 intron CTD PMID:30157460 methotrexate affects response to substance ISO RGD:1346073 6480464 SLC27A2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methotrexate increases expression ISO RGD:1346073 6480464 Methotrexate results in increased expression of SLC27A2 mRNA CTD PMID:17400583 methotrexate affects expression ISO RGD:737177 6480464 Methotrexate affects the expression of SLC27A2 mRNA CTD PMID:18502557 methylmercury chloride multiple interactions ISO RGD:737177 6480464 [Cadmium Chloride co-treated with methylmercuric chloride] results in increased expression of SLC27A2 mRNA CTD PMID:27814245 N-acetyl-L-cysteine multiple interactions EXP 6480464 [Acetylcysteine co-treated with Dietary Fats] results in increased expression of SLC27A2 mRNA CTD PMID:21051528 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC27A2 mRNA CTD PMID:17602206 nicotinic acid increases expression ISO RGD:1346073 6480464 Niacin results in increased expression of SLC27A2 mRNA CTD PMID:24767308 olanzapine increases expression ISO RGD:737177 6480464 Olanzapine results in increased expression of SLC27A2 mRNA CTD PMID:31437515 olanzapine increases expression ISO RGD:1346073 6480464 Olanzapine results in increased expression of SLC27A2 mRNA CTD PMID:31437515 oleic acid multiple interactions ISO RGD:1346073 6480464 [6-4-chlorophenylimidazo2 more ... CTD PMID:30611723 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of SLC27A2 mRNA CTD PMID:19483382 p-chloromercuribenzoic acid increases expression ISO RGD:1346073 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC27A2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SLC27A2 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SLC27A2 mRNA CTD PMID:27188386 paracetamol multiple interactions ISO RGD:737177 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A2 mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol decreases expression ISO RGD:737177 6480464 Acetaminophen results in decreased expression of SLC27A2 mRNA CTD PMID:29246445 paracetamol affects expression ISO RGD:1346073 6480464 Acetaminophen affects the expression of SLC27A2 mRNA CTD PMID:25704631 paracetamol decreases expression ISO RGD:1346073 6480464 Acetaminophen results in decreased expression of SLC27A2 mRNA CTD PMID:26690555 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC27A2 mRNA CTD PMID:15120968 perfluorohexanesulfonic acid increases expression ISO RGD:737177 6480464 perfluorohexanesulfonic acid results in increased expression of SLC27A2 mRNA CTD PMID:21705711 perfluorononanoic acid increases expression ISO RGD:1346073 6480464 perfluorononanoic acid results in increased expression of SLC27A2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid affects expression ISO RGD:737177 6480464 perfluorooctane sulfonic acid affects the expression of SLC27A2 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1346073 6480464 perfluorooctane sulfonic acid results in increased expression of SLC27A2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:737177 6480464 perfluorooctane sulfonic acid results in increased expression of SLC27A2 mRNA CTD PMID:20936131 , PMID:21705711 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of SLC27A2 mRNA CTD PMID:18692542 , PMID:19162173 perfluorooctanoic acid affects expression ISO RGD:737177 6480464 perfluorooctanoic acid affects the expression of SLC27A2 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression ISO RGD:1346073 6480464 perfluorooctanoic acid results in increased expression of SLC27A2 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC27A2 mRNA CTD PMID:28511854 perfluorooctanoic acid multiple interactions ISO RGD:737177 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of SLC27A2 mRNA] CTD PMID:18467677 perfluorooctanoic acid increases expression ISO RGD:737177 6480464 perfluorooctanoic acid results in increased expression of SLC27A2 mRNA CTD PMID:17681415 , PMID:18467677 phenobarbital affects expression ISO RGD:1346073 6480464 Phenobarbital affects the expression of SLC27A2 mRNA CTD PMID:19084549 pirinixic acid multiple interactions ISO RGD:737177 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC27A2 mRNA, PPARA protein affects the reaction [pirinixic acid results in increased expression of SLC27A2 mRNA] CTD PMID:15777286 , PMID:18489776 pirinixic acid increases expression ISO RGD:737177 6480464 pirinixic acid results in increased expression of SLC27A2 mRNA CTD PMID:15777286 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC27A2 mRNA CTD PMID:19162173 more ... pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of SLC27A2 mRNA CTD PMID:19483382 potassium chromate multiple interactions ISO RGD:1346073 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of SLC27A2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1346073 6480464 potassium chromateVI results in increased expression of SLC27A2 mRNA CTD PMID:22714537 potassium chromate decreases expression ISO RGD:1346073 6480464 potassium chromateVI results in decreased expression of SLC27A2 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:737177 6480464 Potassium Dichromate results in decreased expression of SLC27A2 mRNA CTD PMID:23608068 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of SLC27A2 mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:737177 6480464 Pravastatin results in decreased expression of SLC27A2 mRNA CTD PMID:27225895 progesterone multiple interactions ISO RGD:737177 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SLC27A2 mRNA CTD PMID:19693291 propamocarb decreases expression ISO RGD:737177 6480464 propamocarb results in decreased expression of SLC27A2 mRNA CTD PMID:29137890 quercetin decreases expression ISO RGD:1346073 6480464 Quercetin results in decreased expression of SLC27A2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1346073 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SLC27A2 mRNA CTD PMID:19167446 rifampicin increases expression ISO RGD:1346073 6480464 Rifampin results in increased expression of SLC27A2 mRNA CTD PMID:27199754 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC27A2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium arsenite multiple interactions ISO RGD:737177 6480464 [bisphenol A co-treated with sodium arsenite] results in increased expression of SLC27A2 mRNA CTD PMID:30208560 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SLC27A2 mRNA CTD PMID:22561333 sulforaphane increases expression ISO RGD:737177 6480464 sulforafan results in increased expression of SLC27A2 mRNA CTD PMID:30529165 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of SLC27A2 mRNA CTD PMID:15885361 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of SLC27A2 protein CTD PMID:24090815 tert-butyl hydroperoxide affects expression ISO RGD:1346073 6480464 tert-Butylhydroperoxide affects the expression of SLC27A2 mRNA CTD PMID:23410634 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of SLC27A2 mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:737177 6480464 Testosterone results in increased expression of SLC27A2 mRNA CTD PMID:19693291 tetrachloroethene increases expression ISO RGD:737177 6480464 Tetrachloroethylene results in increased expression of SLC27A2 mRNA CTD PMID:28973375 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SLC27A2 mRNA CTD PMID:15963342 tetrachloromethane decreases expression ISO RGD:737177 6480464 Carbon Tetrachloride results in decreased expression of SLC27A2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC27A2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC27A2 mRNA CTD PMID:31150632 tetracycline decreases expression ISO RGD:737177 6480464 Tetracycline results in decreased expression of SLC27A2 mRNA CTD PMID:24489787 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of SLC27A2 mRNA CTD PMID:19483382 trichloroethene increases expression ISO RGD:737177 6480464 Trichloroethylene results in increased expression of SLC27A2 mRNA CTD PMID:28973375 trichostatin A increases expression ISO RGD:1346073 6480464 trichostatin A results in increased expression of SLC27A2 mRNA CTD PMID:24935251 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SLC27A2 mRNA CTD PMID:21515302 tunicamycin increases expression ISO RGD:1346073 6480464 Tunicamycin results in increased expression of SLC27A2 mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:737177 6480464 Valproic Acid affects the expression of SLC27A2 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:737177 6480464 Valproic Acid results in decreased expression of SLC27A2 mRNA CTD PMID:24896083 valproic acid increases expression ISO RGD:1346073 6480464 Valproic Acid results in increased expression of SLC27A2 mRNA CTD PMID:23179753 more ... vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of SLC27A2 gene CTD PMID:31079544 vorinostat multiple interactions ISO RGD:1346073 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SLC27A2 mRNA CTD PMID:27188386 zidovudine increases expression ISO RGD:1346073 6480464 Zidovudine results in increased expression of SLC27A2 mRNA CTD PMID:24292225 zoledronic acid decreases expression ISO RGD:1346073 6480464 zoledronic acid results in decreased expression of SLC27A2 mRNA CTD PMID:24714768 , PMID:25596134 zoledronic acid multiple interactions ISO RGD:737177 6480464 SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA] more ... CTD PMID:28871336 zoledronic acid increases expression ISO RGD:1346073 6480464 zoledronic acid results in increased expression of SLC27A2 mRNA, zoledronic acid results in increased expression of SLC27A2 protein CTD PMID:28871336 zoledronic acid increases expression ISO RGD:737177 6480464 zoledronic acid results in increased expression of SLC27A2 mRNA, zoledronic acid results in increased expression of SLC27A2 protein CTD PMID:28871336